CHEYENNE, WY / ACCESSWIRE / December 11, 2020 / MJ Biotech, Inc. (OTCQB:MJTV), is pleased to announce that given the global COVID-19 (coronavirus) healthcare crisis and the nationwide acute shortage of testing supplies, MJ BIOTECH INC. has entered the Professional medical testing sector and has IN STOCK FOR IMMEDIATE DELIVERY Emergency Use Authorized COVID-19 “Coronavirus” IgG/IgM Rapid Test Kits.
These Kits are very much in demand at present, and we anticipate an even larger demand in preparation for the Vaccines that will shortly be on the market. Our Rapid Test Kits purchaser is the Medical Professional Market, not the individual consumer.
ADVERTISEMENT The MJ Biotech, Inc. marketing for distribution is for Commercial Healthcare Professionals and Professional Medical Purchasers only.
Our purchasers are laboratories, physicians, Indian Health Services, clinics, medical offices, hospitals and university health services.
We are currently establishing an experienced Medical/Pharmaceutical Representative sales force to distribute and engage the Medical Community.
The Coronavirus IgG/IgM Rapid Test Kits are also featured on our web site for the professional medical market only at www.mjbiotech.us
The test kits are approved by the FDA for Emergency Use Authorizations. (EUA) to get information on the Emergency Use Authorizations (EUAs) for diagnostic, non-diagnostic, and therapeutic medical devices that CDRH has issued related to COVID-19: for more information about the kits please go to
Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices | FDA
Give Me A Follow If You Want To Consistently Find Winners!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.